Skip to content

Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02752997
Enrollment
24
Registered
2016-04-27
Start date
2015-12-31
Completion date
2016-03-31
Last updated
2016-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Patient Readmission

Brief summary

Patients admitted for heart failure that are provided discharge medication services by a pharmacist are less likely to be readmitted within 30 days of primary admission.

Interventions

OTHERPharmacist discharge medication services

Included in arm descriptions

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of heart failure, discharged from any medical service

Exclusion criteria

* Unwilling to participate, discharged to nursing/rehab facility, non-English speaking, resident unavailable

Design outcomes

Primary

MeasureTime frameDescription
Number of patients readmitted to the hospital within 30 days of primary heart failure admission30 DaysFisher's T-test

Secondary

MeasureTime frameDescription
Number of patients who visit the emergency department within 30 days of primary heart failure admission30 DaysFisher's T-test
Number of medication discrepancies identified and the number of medication discrepancies resolved by the pharmacist at discharge.30 DaysFisher's T-test
Number of short term goals set by patient's at discharge and the number of short term goals met by patient's at the 7-10 follow up phone call.30 daysNumber of short term goals set will be compared to the number of goals patients achieved, comparison will be calculated by percentage

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026